TELA Bio, Inc. (NASDAQ:TELA) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Hannah Jeffrey - The Gilmartin Group Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Andrew Stafford - Piper Sandler Frank Pinal - Jefferies Kyle Rose - Canaccord Genuity David Turkaly - JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2021 E ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37526 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other juri ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37526 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdict ...

TELA Bio, Inc. (NASDAQ:TELA) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations Tony Koblish – President and Chief Executive Officer Megan Smeykal – Vice President and Corporate Controller Conference Call Participants Drew Stafford – Piper Jaffray Operator Good day and thank you for standing by. Welcome to the TELA Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentati ...

Advancing Soft Tissue Reconstruction Investor Presentation May 2021 Forward Looking Statements This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this document, including but not limited to statements regarding possible or assumed future results of operations, business strategies, development plans, regulatory activities, market opportunity competitive position ...

TELA Bio Inc. (NASDAQ:TELA) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Hannah Jeffrey - Gilmartin Group Tony Koblish - President and CEO Nora Brennan - CFO Conference Call Participants Anthony Petrone - Jefferies Dave Turkaly - JMP Securities Kyle Rose - Canaccord Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware (State or other jurisdiction of incorporation or organization) 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania (Address o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37526 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction ...

TELA Bio Inc (NASDAQ:TELA) Q4 2020 Earnings Conference Call March 24, 2021 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group, IR Antony Koblish - President and CEO Nora Brennan - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Anthony Petrone - Jefferies Kyle Rose - Canaccord Genuity Dave Turkaly - JMP Securities Operator Ladies and gentlemen, thank you for standing by. Welcome to the TELA Bio Fourth Quarter Earnings Conference Call. At this time, all part ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR Delaware (State or other jurisdiction of incorporation or organization) 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania (Address of principal executive offices) (484) 320-2930 (Registrant's telephone number, including area code) Securities registered ...